Steris | STE - Gross Profit On Sales


Steris reported $684.2M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
3M USD 2.68B 227M Jun/2026
Accuray USD 41.89M 7.42M Dec/2024
Baxter International USD 1.14B 251M Jun/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Boston Scientific USD 3.82B 210M Jun/2026
CONMED USD 197.46M 14.01M Jun/2026
Cooper Companies USD 711.9M 23.5M Jun/2026
Dexcom USD 750.3M 42.4M Mar/2026
Ecolab USD 1.78B 65.5M Mar/2026
Edwards Lifesciences USD 1.35B 62.6M Jun/2026
Fortive USD 695.3M 19.8M Jun/2026
Getinge SEK 4.42B 638M Jun/2026
Globus Medical USD 548.17M 51.91M Jun/2026
Haemonetics USD 202.8M 4.59M Jun/2026
Idexx Laboratories USD 779.09M 56.35M Jun/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 562.6M 21.8M Jun/2026
Integra LifeSciences USD 215.97M 2.77M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Olympus JPY 156.83B 35.93B Jun/2026
Orthofix International USD 153.28M 4.76M Dec/2025
Owens Minor USD 272.05M 20.92M Dec/2025
ResMed USD 861.22M 29.76M Jun/2026
Steris USD 684.2M 12.9M Jun/2026
Stryker USD 4.5B 688M Jun/2026
Tandem Diabetes Care USD 144.78M 7.99M Jun/2026
Teleflex USD 331.71M 24.28M Jun/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Zimmer Biomet Holdings USD 1.36B 149.4M Jun/2026